Previous 10 | Next 10 |
2024-06-06 20:59:58 ET Summary The Schwab U.S. Dividend Equity ETF has performed reasonably well over the years. However it has underperformed a similar strategy, which is buying a diversified portfolio of Dividend Aristocrat stocks. The Dividend Aristocrats have beaten the S&...
2024-06-06 12:38:52 ET Summary FibroGen, Inc. top-line data from the phase 2/3 PanCAN Precision Promise study, using pamrevlumab for the treatment of patients with metastatic pancreatic cancer, expected mid-2024. Topline data from the phase 3 LAPIS study, using pamrevlumab for the...
2024-06-06 09:30:00 ET Summary I had a 'Hold/Neutral' stance on Pfizer in my last update, but the stock has performed worse than my expectations; lagging the S&P 500 by 8.46%. Yet, I maintain my stance. I've been skeptical of Pfizer's expensive acquisition of Seagen. I believe...
2024-06-06 09:00:00 ET Summary The Dividend Harvesting Portfolio generated over $100 of dividend income in May, with a return on invested capital of 14.14%. The portfolio's diversification helped stabilize market conditions, with a 1.45% growth in profitability despite market decl...
2024-06-06 08:04:56 ET More on Sanofi, Novavax, etc. Novavax: Sanofi Partnership Revitalizes My Magnum Opus Novavax, Inc. (NVAX) Q1 2024 Earnings Call Transcript Novavax Ditches 'Going Concern,' Embraces Sanofi Safety Net (Rating Upgrade) Bird flu death in Me...
2024-06-05 23:35:22 ET Summary Pfizer's stock is currently trading below pre-pandemic levels, despite the record-breaking year it had in 2023 for FDA approvals and the significant acquisition of Seagen. Weak sentiment is likely explained by the significant risk of two best-selling...
2024-06-05 16:48:37 ET More on GSK, Moderna, etc. GSK plc: Long-Term Cash Cow FDA advisors unanimously agree on COVID JN.1-lineage vaccine for fall COVID vaccine makers ready updated shots for fall immunization drive Moderna, Inc. (MRNA) Moderna Oncology Inve...
2024-06-05 16:30:31 ET More on vaccine makers Pfizer: The Chart Looks Like A Bottom, But Is The Dividend Safe? COVID vaccine makers ready updated shots for fall immunization drive Pfizer data for breast cancer therapy sends Olema higher Moderna, Inc. (MRNA) M...
CAMBRIDGE, Mass., June 05, 2024 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, today announced a clinical trial collabor...
2024-06-05 12:44:27 ET More on iShares MSCI ACWI ETF: ACWI: Balanced Exposure To Global Markets Is Mature, But Reward Looks Unattractive Equities are still modestly cheap even if Gen AI pushes productivity up - UBS News have trended negatively against the ACWI - BofA...
News, Short Squeeze, Breakout and More Instantly...
2024-07-22 05:59:00 ET Both Pfizer (NYSE: PFE) and Roche Holdings (OTC: RHHBY) rank among the world's most powerful pharmaceutical companies. Yet neither is actively competing in the all-important market for weight loss drugs, which is currently being split between the likes...
2024-07-20 10:00:00 ET On July 11, Pfizer (NYSE: PFE) made an announcement that came as a bit of a surprise to biopharma industry experts and Wall Street analysts alike. It's planning on advancing one of its early-stage weight loss programs into mid-stage trials. In due time, the mo...
2024-07-18 13:06:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...